Augment Biologics
Better Medicine Through Better Surface Engineering
San Francisco, United States · Founded 2021 · $7.7M raised
- Headquarters
- San Francisco, California
- Founded
- 2021
- Business Model
- B2B
- Website
- augmentbiologics.com
- Total Funding
- $7.7M
- Last Round
- $150K SeedAug 2025
- Rounds
- 2
About
Augment Biologics is a platform-enabled biopharmaceutical company using foundational discoveries in glycobiology to transform biologic drug development. The company developed GlycoTemplating, an AI-guided glycoprotein-drug design platform that writes glycans directly into the primary protein sequence with site-specific accuracy. Unlike traditional glycoengineering methods, GlycoTemplating is expression-platform-agnostic and improves drug efficacy, safety, durability, and manufacturability. The platform is built on discoveries in glycan biosynthesis from the Lewis Lab at UCSD and the University of Georgia. Near-term applications focus on antibody, protein, and peptide engineering; long-term applications extend to RNA therapeutics, delivery vehicles, and vaccine development. In 2025, the company joined the Recode Ventures Edge cohort and was selected for MassBio Drive.
Summary
Augment Biologics is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. It has raised $7.7M in total across 2 rounds, most recently a $150K Seed round in Aug 2025. Investors include SOSV and IndieBio.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...